(Q34634358)

English

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

0 references

High-dose statin pretreatment decreases periprocedural myocardial infarction and cardiovascular events in patients undergoing elective percutaneous coronary intervention: a meta-analysis of twenty-four randomized controlled trials (English)

1 reference

Europe PubMed Central

3 August 2017

myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Le Wang

1

1 reference

Europe PubMed Central

3 August 2017

Pingan Peng

2

1 reference

Europe PubMed Central

3 August 2017

Ou Zhang

3

1 reference

Europe PubMed Central

3 August 2017

Xiaohan Xu

4

1 reference

Europe PubMed Central

3 August 2017

Shiwei Yang

5

1 reference

Europe PubMed Central

3 August 2017

Yingxin Zhao

6

1 reference

Europe PubMed Central

3 August 2017

Yujie Zhou

7

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

4 December 2014

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

9

1 reference

Europe PubMed Central

3 August 2017

12

1 reference

Europe PubMed Central

3 August 2017

e113352

1 reference

Europe PubMed Central

3 August 2017

copyright license

Creative Commons Attribution 4.0 International

4 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Peri-procedural myocardial injury: 2005 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Myonecrosis after revascularization procedures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

7 July 2018

Effectiveness of in-laboratory high-dose clopidogrel loading versus routine pre-load in patients undergoing percutaneous coronary intervention: results of the ARMYDA-5 PRELOAD (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplas

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Preloading with atorvastatin before percutaneous coronary intervention in statin-naïve Asian patients with non-ST elevation acute coronary syndromes: A randomized study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Can a high reloading dose of atorvastatin prior to percutaneous coronary intervention reduce periprocedural myocardial infarction?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Randomized trial of statin administration for myocardial injury: is intensive lipid-lowering more beneficial than moderate lipid-lowering before percutaneous coronary intervention?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

The effects and mechanisms of high loading dose rosuvastatin therapy before percutaneous coronary intervention in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Long-term prognostic value of preprocedural C-reactive protein after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angiopl

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Ang

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in female patients with non-ST-segment elevation acute coronary syndrome.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

26 October 2018

Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4256370

26 October 2018

Effect of Two-Day Atorvastatin Pretreatment on Long-Term Outcome of Patients With Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Effect of seven-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following percutaneous coronary intervention in patients receiving long-term statin therapy. A randomized study

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0113352

21 January 2018

Does pravastatin therapy affect cardiac enzyme levels after percutaneous coronary intervention?

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of intensive statin use on the level of inflammation and platelet activation in stable angina after percutaneous coronary intervention: a clinical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/25473831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0113352

1 reference

Europe PubMed Central

3 August 2017

2014PLoSO...9k3352W

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34634358&oldid=1859462440"